Insider Transactions in Q1 2022 at Encompass Health Corp (EHC)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
209
+50.0%
|
-
|
|
Feb 25
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,406
+10.41%
|
-
|
|
Feb 25
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,870
+15.0%
|
-
|
|
Feb 25
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,426
+8.22%
|
-
|
|
Feb 25
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
4,309
+2.3%
|
-
|
|
Feb 25
2022
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
BUY
Grant, award, or other acquisition
|
Direct |
15,772
+12.42%
|
-
|
|
Feb 25
2022
|
Andrew L Price Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,582
+3.39%
|
-
|
|
Feb 25
2022
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,988
+5.41%
|
-
|
|
Feb 24
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-1.51%
|
$19,240
$65.52 P/Share
|
|
Feb 24
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
698
-1.85%
|
$45,370
$65.52 P/Share
|
|
Feb 24
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-0.81%
|
$21,450
$65.52 P/Share
|
|
Feb 24
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-0.28%
|
$16,055
$65.52 P/Share
|
|
Feb 24
2022
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
584
-1.32%
|
$37,960
$65.52 P/Share
|
|
Feb 24
2022
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
265
-0.43%
|
$17,225
$65.52 P/Share
|
|
Feb 24
2022
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-0.49%
|
$121,745
$65.52 P/Share
|
|
Feb 22
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,270
-3.25%
|
$82,550
$65.91 P/Share
|
|
Feb 22
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-3.0%
|
$39,260
$65.91 P/Share
|
|
Feb 22
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
673
-1.63%
|
$43,745
$65.91 P/Share
|
|
Feb 22
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-0.57%
|
$32,955
$65.91 P/Share
|
|
Feb 22
2022
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
1,048
-2.31%
|
$68,120
$65.91 P/Share
|
|
Feb 22
2022
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
525
-0.84%
|
$34,125
$65.91 P/Share
|
|
Feb 22
2022
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,782
-0.98%
|
$245,830
$65.91 P/Share
|
|
Feb 08
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,509
-29.72%
|
$1,023,558
$62.15 P/Share
|
|
Feb 08
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,132
+31.99%
|
$548,772
$21.02 P/Share
|
|
Jan 21
2022
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
399
+19.84%
|
$24,738
$62.51 P/Share
|
|
Jan 20
2022
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+0.4%
|
$30,876
$62.59 P/Share
|
|
Jan 19
2022
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
231
+0.19%
|
$14,091
$61.21 P/Share
|
|
Jan 19
2022
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.01%
|
$427
$61.26 P/Share
|
|
Jan 19
2022
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
67
+0.07%
|
$4,087
$61.17 P/Share
|
|
Jan 18
2022
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.46%
|
-
|
|
Jan 18
2022
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
328
+0.26%
|
-
|
|
Jan 18
2022
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.44%
|
-
|
|
Jan 18
2022
|
Yvonne M Curl Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.44%
|
-
|
|
Jan 18
2022
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.41%
|
-
|
|
Jan 18
2022
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.44%
|
-
|
|
Jan 18
2022
|
Leo I Higdon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+6.66%
|
-
|
|
Jan 18
2022
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.44%
|
-
|
|
Jan 18
2022
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.46%
|
-
|
|
Jan 18
2022
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.42%
|
-
|
|
Jan 18
2022
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.49%
|
-
|
|
Jan 18
2022
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.45%
|
-
|
|
Jan 18
2022
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+0.35%
|
-
|
|
Jan 18
2022
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.43%
|
-
|
|
Jan 03
2022
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-5.65%
|
$78,390
$65.26 P/Share
|
|
Jan 03
2022
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,226
-12.56%
|
$274,690
$65.26 P/Share
|
|
Jan 03
2022
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,537
-5.78%
|
$164,905
$65.26 P/Share
|
|
Jan 03
2022
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.14%
|
$66,625
$65.26 P/Share
|
|
Jan 03
2022
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
3,455
-7.07%
|
$224,575
$65.26 P/Share
|
|
Jan 03
2022
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,031
-1.62%
|
$67,015
$65.26 P/Share
|
|
Jan 03
2022
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,327
-2.85%
|
$736,255
$65.26 P/Share
|